The team consists of public health researchers, specialized in epidemiology and sociology, and clinicians specialized in geriatric medicine, neurology and nutrition. The strong involvement of the clinicians has enabled us to conduct ambitious studies in clinical research, both at the national and international level. Our work is based on the implementation and follow-up of cohorts of patients with Alzheimer's disease and has progressively become oriented towards a more interventional approach with the implementation of original intervention programmes. The methodological originality of our studies is based on a combination of quantitative and qualitative approach.
Expected health effects
The demonstration of the protective effects of certain factors on cognitive decline will enable, in time, the development of prevention programmes aiming to delay the onset of incapacitating pathologies. For the management of dependency, the demonstration of the benefit of certain types of innovative support could enable them to be rolled out on a larger scale.
EADC Bruno Vellas initiated the European Alzheimer Disease Consortium Disease Consortium
IAGG Bruno Vellas is president of International Association of Gerontology and Geriatrics
European Dementia Prevention Initiative (EDPI) : the team has been involved in EDPI since its creation in 2011, which has brought about collaborations, particularly within European projects, with teams from the Academic Medical Centre, University of Amsterdam, the Netherlands (Dr Edo Richard, Dr Eric Moll van Charante, Prof. Willem A. van Gool), the Karolinska Institute, Stockholm, Sweden (Pr Miia Kivipelto, Dr Alina Solomon, Dr Tiia Ngandu) and the University of Cambridge, Royaume Uni (Pr Carol Brayne)
Université de Nouveau Mexique : the team collaborates closely with Prof. Gary Rosenberg (Neuroscience Research, Albuquerque, University of New Mexico, USA)